← Back to Search
Solid Lipid Nanoparticles For Oral Drug Delivery
S. K. Basha, R. Dhandayuthabani, M. Muzammil, V. S. Kumari
Published 2020 · Chemistry
Download PDFAnalyze on Scholarcy
Abstract Solid lipid nanoparticles (SLNs) are an incredibly resourceful drug delivery platform because of its diverse determination and modifiable lipid materials are making the topic exceptionally captivated in the latest year.The network of the SLNs improves drug stability, maintaining a strategic distance from proteolytic debasement after organization, and releasing the drug in a controlled way, which additionally offer a few advantages over ordinary details, including great physical stability, spherical morphology, uniform size, positive zeta potentials, typical high cell penetration efficiency, core–shell pattern and excipients of GRAS status make the SLNs delivery system all the more promising.Subsequently this fresh methodology of solid lipid nanoparticles hold tremendous promise for reaching at the objective of controlled and site exact for both oral and parenteral drug delivery system. The aim of the article is to review the diverse instrumental techniques have been decorated and oral administration of SLNs is logistically reviewed.
This paper references
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
Yifan Luo (2006)
In vitro lipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract
V. Jannin (2015)
Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
A. Dingler (1999)
Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings.
O. Hernell (1990)
Nanosystem drug targeting: Facing up to complex realities.
Pakatip Ruenraroengsak (2010)
Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles
Shuyu Xie (2011)
Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles
Solmaz Ghaffari (2010)
Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
Z. Urbán-Morlán (2010)
Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters.
S. Fernandez (2007)
Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.
M. Schubert (2003)
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery
M. Bondì (2007)
Formulation of solid lipid nanoparticles and their applications.
.. A.Krishnasailaja (2011)
The influence of solid lipid nanoparticles on skin hydration and viscoelasticity--in vivo study.
S. Wissing (2003)
Production of lipospheres as carriers for bioactive compounds.
R. Cortesi (2002)
Drug release and release mechanism of prednisolone loaded Solid Lipid Nanoparticles
A. Z. Mühlen (1998)
Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
B. Lu (2006)
How to design the surface of peptide-loaded nanoparticles for efficient oral bioavailability?
H. Malhaire (2016)
Block copolymers as drug carriers.
M. Yokoyama (1992)
Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design
J. Emami (2015)
Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits.
M. Sznitowska (2001)
Preparation of solid lipid nanoparticles through various methods using different precursors
R. Singh (2019)
Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
S. Motwani (2008)
LIPID-BASED FORMULATIONS FOR ORAL ADMINISTRATION: OPPORTUNITIES FOR BIOAVAILABILITY ENHANCEMENT AND LIPOPROTEIN TARGETING OF LIPOPHILIC DRUGS
C. J. Porter (2001)
Lipid digestion and absorption.
M. Carey (1983)
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
V. Venkateswarlu (2004)
Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
P. Chattopadhyay (2007)
In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel.
D. Chen (2001)
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism
R. Parhi (2010)
Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats
M. J. Ansari (2016)
Drug encapsulation using supercritical fluid extraction of emulsions.
P. Chattopadhyay (2006)
Fate of lipid vesicles in vivo: a gamma-ray perturbed angular correlation study.
K. J. Hwang (1977)
Preparation and Characterization of Solid Lipid Nanoparticles Containing Silibinin
J. Zhang (2007)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery
M. Bhalekar (2009)
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
Development of terbinafine solid lipid nanoparticles as a topical delivery system
Y. Chen (2012)
Optimization of Spray-Dried and -Congealed Lipid Micropellets and Characterization of Their Surface Morphology by Scanning Electron Microscopy
T. Eldem (2004)
This paper is referenced by
Bioavailability and palatability of praziquantel incorporated into solid-lipid nanoparticles fed to yellowtail kingfish Seriola lalandi.
G. Partridge (2019)
Colloidal lipid nanodispersion enriched hydrogel of antifungal agent for management of fungal infections: comparative in-vitro, ex-vivo and in-vivo evaluation for oral and topical application.
N. Dudhipala (2020)
Rethinking carbamazepine oral delivery using polymer‐lipid hybrid nanoparticles
R. Ana (2019)